Search Within

Hematologic Malignancies Service

Formats
  1. Journal Article (350)
  2. Meeting Abstract (237)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Correspondence (1)
Groups
  1. Pediatrics, Department of (614)
  2. Center for Hematologic Malignancies (557)
  3. Pediatric Leukemia (457)
  4. GSK Faculty (222)
  5. Tow Center for Developmental Oncology (TCDO) (208)
  6. Department of Medicine (150)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (161)
  3. Tanya Trippett (126)
  4. Alex Kentsis (104)
  5. Christopher Forlenza (51)
  6. Marc Ladanyi (45)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (130)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Clinical Cancer Research (16)

More Publications

Publishers
  1. American Society of Hematology (139)
  2. American Society of Clinical Oncology (69)
  3. American Association for Cancer Research (57)
  4. Wiley Periodicals, Inc (57)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (31)

More Publishers

Results (614)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results from an intergroup randomized phase II study of the combinations of ipilimumab, nivolumab and brentuximab vedotin in patients with relapsed/refractory classic Hodgkin lymphoma: A trial of the ECOG-ACRIN Research Group (E4412)
    Meeting Abstract

    Diefenbach, C. S.; Jegede, O.; Ansell, S. M.; Steidl, C.; Natkunam, Y.; Scott, D. W.; Mehta-Shah, N.; Amengual, J. E.; Forlenza, C. J.; Cole, P. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of venetoclax and selinexor in combination with chemotherapy in pediatric and young adult patients with relapsed or refractory acute myeloid leukemia: SELCLAX
    Meeting Abstract

    Zarnegar-Lumley, S.; Karol, S. E.; Pounds, S.; Klco, J. M.; Sulis, M. L.; Kuo, D. J.; Heym, K. M.; Ludwig, K.; Stevens, A. M.; Alexander, T. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Pembrolizumab (pembro) in children and young adults with low-risk classical Hodgkin lymphoma (cHL) with slow early response (SER) to front-line chemotherapy (chemo): Early results from the phase 2 KEYNOTE-667 study
    Meeting Abstract

    Roth, L. G.; Keller, F.; Toledo, M. M.; Castellino, S. M.; Forlenza, C. J.; Catalan, M. A.; Krystal, J.; Lamble, A.; Rao, A. V.; Morales, F. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revumenib monotherapy in patients with relapsed/refractory KMT2Ar acute leukemia: Topline efficacy and safety results from the pivotal Augment-101 phase 2 study
    Meeting Abstract

    Aldoss, I.; Issa, G. C.; Thirman, M.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G. N.; Perl, A.; Dickens, D. S.; McMahon, C. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical targeted next-generation panel sequencing reveals MYC amplification is a poor prognostic factor in osteosarcoma
    Journal Article

    Marinoff, A. E.; Spurr, L. F.; Fong, C.; Li, Y. Y.; Forrest, S. J.; Ward, A.; Doan, D.; Corson, L.; Mauguen, A.; Pinto, N.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Epigenetic cooperativity as a therapeutic vulnerability in cancer
    Editorial

    Kazansky, Y.; Kentsis, A.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • EZH2 inhibition: It's all about the context
    Editorial

    Rosen, E. Y.; Shukla, N. N.; Glade Bender, J. L.
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression
    Review

    Juul-Dam, K. L.; Shukla, N. N.; Cooper, T. M.; Cuglievan, B.; Heidenreich, O.; Kolb, E. A.; Rasouli, M.; Hasle, H.; Zwaan, C. M.
    European Journal of Medical Genetics (2023)

    Fulltext@MSK | Save
  • Integration of genomic sequencing drives therapeutic targeting of PDGFRA in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma
    Journal Article

    Paolino, J.; Dimitrov, B.; Apsel Winger, B.; Sandoval-Perez, A.; Rangarajan, A. V.; Ocasio-Martinez, N.; Tsai, H. K.; Li, Y.; Robichaud, A. L.; Khalid, D.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Institutional experience of routine genomic profiling of cell-free DNA from cerebrospinal fluid across a wide range of malignancies
    Meeting Abstract

    Hickman, R.; Miller, A.; Jee, J.; Liu, S.; Pentsova, E.; Holle, B.; Ross, D.; Nandakumar, S.; Vanderbilt, C.; Rana, S.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save